The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers’ bottom lines.
Continue reading The 10 Biggest-Selling Drugs That Are About to Lose Their Patent
The 10 Biggest-Selling Drugs That Are About to Lose Their Patent originally appeared on DailyFinance on Sun, 27 Feb 2011 08:00:00.
Filed Under: Company News, Investing, Health Care, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Merck, Eli Lilly, Astrazeneca